London, England, United Kingdom The main department of described VC is located in the London. The fund was located in Europe if to be more exact in United Kingdom.
The important activity for fund was in 2001. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2011. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 6 partakers. Despite the Technomark Medical Ventures, startups are often financed by West Deutsche Landesbank Girozentrale, Excalibur Fund Managers. The meaningful sponsors for the fund in investment in the same round are West Deutsche Landesbank Girozentrale, Temasek Holdings, Scottish Equity Partners. In the next rounds fund is usually obtained by Scottish Equity Partners, Triathlon Medical Venture Partners, New Science Ventures.
For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline BioVex Among the most popular fund investment industries, there are Medical, Biotechnology.
Related Funds
| Fund Name | Location |
| By-Health | China, Guangdong, Zhuhai |
| Citation Strategic Partners | - |
| CITIC Limited | China, Hong Kong, Hong Kong Island |
| Eclectic Fund | - |
| Growth Capital Partners | England, London, United Kingdom |
| Haofang Capital | - |
| Holland Venture | Amsterdam, Noord-Holland, The Netherlands |
| Jarnac Capital Management | - |
| Jungheinrich | Germany, Hamburg |
| Losa Group | Guatemala, Guatemala City |
| Maytag Corporation | Benton Harbor, Michigan, United States |
| NALA Investments | California, Santa Monica, United States |
| Purpose Venture Capital | Central, Central Region, Singapore |
| SAMTAK | China, Jinan, Shandong |
| SHO-BOND | Chuo, Japan |
| The Angels' Forum | California, Mountain View, United States |
| Tianjin Renai Capital | China, Jinghai, Tianjin |
| Xietingge Touzi | Chengdu, China, Sichuan |
| Yunding Capital | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BioVex | $23M | 06 Oct 2003 | United Kingdom, England, United Kingdom | ||
BioVex | $13M | 30 Jul 2001 | United Kingdom, England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
BioVex | $23M | 06 Oct 2003 | United Kingdom, England, United Kingdom | ||
BioVex | $13M | 30 Jul 2001 | United Kingdom, England |
